IN8bio, Inc. (INAB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.95M | -2.14M | -3.52M | -3.93M | -3.12M | -4.03M | -6.11M | -6.09M | -7.92M | -4.85M | -5.71M | -5.34M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -58.46% | 46.9% | 42.33% | 35.53% | 60.58% | 16.95% | -6.97% | -14.11% | -6.45% | 38.99% | 0.49% | 9.09% |
| Net Income | -5.09M | -4.94M | -3.85M | -5.09M | -5.55M | -6.16M | -7.09M | -8.63M | -8.56M | -7.6M | -7.17M | -7.71M |
| Depreciation & Amortization | 353K | 537K | 401K | 541K | 669K | 702K | 690K | 631K | 632K | 627K | 647K | 637K |
| Stock-Based Compensation | 401K | 711K | 0 | 955K | 831K | 825K | 1.76M | 1.17K | 1.24M | 1.25M | 1.24M | 1.02M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.31M | 0 | 0 |
| Other Non-Cash Items | -611K | -16K | 818K | 243K | 0 | 0 | 45K | 1.17M | 0 | 2.31M | 0 | 0 |
| Working Capital Changes | 0 | 1.57M | -889K | -572K | 928K | 605K | -1.52M | 736K | -1.23M | 869K | -431K | 721K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 140K | 105K | -175K | -196K | 186K | -746K | -307K | 29K | 489K | 200K | 209K | -355K |
| Cash from Investing | -9K | 0 | 0 | 0 | 0 | -33K | 0 | -83K | -71K | -72K | -77K | -22K |
| Capital Expenditures | -9K | 0 | 0 | 0 | 0 | -33K | 0 | -83K | -71K | -72K | -77K | -22K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -195K | 18.49M | 989K | 5.27M | 3.89M | 11.19M | -105K | 3.38M | -277K | 13.35M | 1.65M | 11.49M |
| Debt Issued (Net) | 0 | -111K | -123K | -234K | -225K | -219K | -213K | -174K | -188K | -173K | -236K | -214K |
| Equity Issued (Net) | 0 | 18.6M | 1.11M | 5.5M | 4.12M | 11.41M | 108K | 3.53M | -89K | 10.25M | 1.89M | 11.71M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -195K | 0 | 0 | 0 | 0 | 0 | 0 | 25K | 0 | 3.28M | 0 | 0 |
| Net Change in Cash | -5.15M | 16.35M | -2.54M | 1.34M | 771K | 7.12M | -6.22M | -2.8M | -8.27M | 8.43M | -4.14M | 6.13M |
| Free Cash Flow | -4.96M | -2.14M | -3.52M | -3.93M | -3.12M | -4.06M | -6.11M | -6.17M | -7.99M | -4.92M | -5.79M | -5.36M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -58.74% | 47.33% | 42.33% | 36.39% | 60.93% | 17.49% | -5.54% | -15.19% | -1.55% | 46.57% | 22.85% | 14.88% |
| FCF per Share | -0.25 | -0.49 | -0.78 | -0.95 | -0.04 | -0.07 | -0.13 | -0.14 | -0.18 | -0.14 | -0.18 | -0.19 |
| FCF Conversion (FCF/Net Income) | 0.97x | 0.43x | 0.91x | 0.77x | 0.56x | 0.65x | 0.86x | 0.71x | 0.92x | 0.64x | 0.80x | 0.69x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |